MK-2866 + GW-501516 Research Stack in Canada
This research stack contains MK-2866 (Ostarine / Enobosarm) and GW-501516 (Cardarine) as 2 separate, labelled liquid research solutions. The compounds are not premixed. The bundle is intended for laboratory identification, comparative documentation, and controlled research inventory; it is not a dietary supplement, medication, or product for human or veterinary use.
Stack specifications
| Compound | Listed concentration | Volume | Total listed compound | Documentation |
|---|---|---|---|---|
| MK-2866 (Ostarine / Enobosarm) | 25 mg/mL | 30 mL | 750 mg | View raw-material testing |
| GW-501516 (Cardarine) | 20 mg/mL | 30 mL | 600 mg | View raw-material testing |
How this research bundle is organized
This is a mixed-class research bundle: MK-2866 is a SARM, while GW-501516 belongs to PPAR-delta agonist research.
This two-compound listing keeps comparison limited to MK-2866 and GW-501516. Each remains in its own container, making identity and documentation review more direct than in a three-compound catalogue bundle.
Separate containers preserve product identity and make it possible to review the label, concentration, storage information, and current compound documentation for each material independently. The stack name describes a catalogue bundle only; it does not claim synergy, compatibility, safety, or a combined effect.
Compound background
Each bottle in this stack is also listed on its own. Those listings carry each compound’s identifiers, research background, Canadian status and raw-material COA: MK-2866 (Ostarine) 25 mg/mL and GW-501516 (Cardarine) 20 mg/mL.
The studies behind those summaries used specific designs and populations. A catalogue bundle is not evidence that combining these materials is safe or effective.
Why separate bottles and specifications matter
Each included solution has its own concentration and total listed amount. Keeping the compounds separate supports clearer inventory records, analytical sampling, and documentation review.
Researchers should record each compound separately and use the label and applicable documentation associated with that individual product. The presence of multiple products in one order does not create evidence about interactions between them.
Research-use boundaries and handling
Every product in this bundle is sold strictly for laboratory and research purposes. The products are not intended for human consumption, therapeutic use, bodybuilding use, athletic performance use, veterinary use, or the diagnosis, treatment, cure, or prevention of disease.
Keep every container sealed and follow its own label or accompanying storage information. Do not assume that different compounds or carrier systems have identical handling requirements. Contact support with questions about interpreting a report or identifying a different batch.
Frequently asked questions
What is included in this research stack?
The bundle includes one 30 mL bottle of MK-2866 (Ostarine / Enobosarm) at 25 mg/mL and one 30 mL bottle of GW-501516 (Cardarine) at 20 mg/mL. All containers are separately labelled.
Are the compounds premixed?
No. Each compound is supplied in its own bottle so identity, concentration, storage, sampling, and documentation can be managed separately.
Are all included compounds SARMs?
This is a mixed-class research bundle: MK-2866 is a SARM, while GW-501516 belongs to PPAR-delta agonist research.
Does this page provide a dosage, cycle, or combination protocol?
No. This page describes product identity, format, documentation, and published research context only. It does not provide administration, dosage, cycle, stacking, bodybuilding, or medical instructions.



Reviews
There are no reviews yet.